Avro
Waterloo
About Avro
Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.2M
- Last round: Series Unknown (Jan 2021)
- Website: avrolifesci.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/avro-19430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.